Illumina TruSight RNA Pan-Cancer Panel
Illumina has launched the TruSight RNA Pan-Cancer Panel for comprehensive analysis of the cancer transcriptome. The panel targets 1,385 cancer-related transcripts and genes known to be involved in gene fusions, and provides gene expression information, variant calling, and fusion detection with known and novel gene fusion partners. The kit is designed for use with a wide range of sample types, and can be used with as little as 10 ng of total RNA input, or 20 ng from formalin-fixed, paraffin-embedded tissue, and can be used with as little. The panel is compatible with Illumina's NextSeq 500 and MiSeq sequencing systems.